GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biovail Corporation (BVF) [hlAlert]

Rating:
Buy BVF
up 2,035.45 %

Biovail Corporation (BVF) rated Buy with price target $16 by Deutsche Securities

Posted on: Friday,  May 8, 2009  8:25 AM ET by Deutsche Securities

Deutsche Securities rated Buy Valeant Pharmaceuticals International Inc (NYSE: VRX) on 05/08/2009, when the stock price was $11.00.
Since then, Valeant Pharmaceuticals International Inc has gained 2035.45% as of 01/06/2016's recent price of $234.90.
If you would have followed this Deutsche Securities's recommendation on VRX, you would have gained 2035.45% of your investment in 2434 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

Deutsche Bank's award-winning Research team manages a range of functions from asset allocation, through economic forecasting across a broad range of industry sectors including cement and construction, chemicals, electronics, energy, engineering, machinery, media, software, tobacco, retailing and utilities, and oil and gas.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy